Ovation Science is pleased to announce that the U.S. Patent and Trademark Office (USPTO) has granted Ovation a patent entitled “Composition and Method for Transdermal Delivery of Cannabidiol (CBD) and 9-Tetrahydrocannabinol (THC)”; (US Patent Number: 11,439,602), with an expiry of February 2041.
Ovation Science has entered into an exclusive licensing agreement for its cannabis formulations for the states of Oklahoma, Missouri, New Mexico and Mississippi with Stash House Distribution (“Stash House”).
Ovation Science has developed new high-dose CBD (Cannabidiol) formulations for both its “health and wellness” and its “beauty” lines.
Ovation Science reports that its topical cannabis products continue to hold five of the top sales positions in the Nevada topical dispensary market.
Ovation Science announces an increase in the sale of its non-alcohol hand sanitizer lotion, DermSafe® to professional and amateur athletes across Canada.
Ovation Science announces an increase in the sale of its non-alcohol hand sanitizer lotion, DermSafe® to professional and amateur athletes across Canada.
Ovation Science has announces it has begun an online campaign to promote its DermSafe® hand sanitizer made without alcohol and powered by the Company’s Invisicare® drug delivery technology.
Ovation Science Inc. is pleased to provide this update on the ongoing research and development of its topical and transdermal cannabis products using its patented skin delivery technology Invisicare®.
Ovation Science reports that sales in January 2021 through its licensee in Nevada outperformed the previous month (December 2020) by over 70%.
Ovation Science has entered into a non-exclusive distribution agreement for its DermSafe® hand sanitizer with CDMV, Canada’s leading distributor of products to veterinary clinics across Canada.
